Results of the largest randomised, controlled study of deep brain stimulation (DBS) in Parkinson’s disease indicate that the therapy improves motor function for up to two years in patients with advanced disease. The trial was sponsored by Medtronic, whose Kinetra device was used ...
Please Login to read the full article.
